左室射血分数降低的高危患者经皮冠状动脉介入治疗被认为不适合手术血运重建。欧洲经皮心血管介入协会(EAPCI)与ESC心血管外科工作组合作的临床共识声明。

IF 7.6 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS
Andreas Schäfer, Mirvat Alasnag, Daniele Giacoppo, Carlos Collet, Tanja K Rudolph, Ariel Roguin, Piotr P Buszman, Roisin Colleran, Giulio Stefanini, Thierry Lefevre, Nicolas Van Mieghem, Guillaume Cayla, Christoph Naber, Andreas Baumbach, Adam Witkowski, Francesco Burzotta, Davide Capodanno, Dariusz Dudek, Rasha Al-Lamee, Adrian Banning, Philip MacCarthy, Roman Gottardi, Florian S Schoenhoff, Martin Czerny, Matthias Thielmann, Nikos Werner, Giuseppe Tarantini
{"title":"左室射血分数降低的高危患者经皮冠状动脉介入治疗被认为不适合手术血运重建。欧洲经皮心血管介入协会(EAPCI)与ESC心血管外科工作组合作的临床共识声明。","authors":"Andreas Schäfer, Mirvat Alasnag, Daniele Giacoppo, Carlos Collet, Tanja K Rudolph, Ariel Roguin, Piotr P Buszman, Roisin Colleran, Giulio Stefanini, Thierry Lefevre, Nicolas Van Mieghem, Guillaume Cayla, Christoph Naber, Andreas Baumbach, Adam Witkowski, Francesco Burzotta, Davide Capodanno, Dariusz Dudek, Rasha Al-Lamee, Adrian Banning, Philip MacCarthy, Roman Gottardi, Florian S Schoenhoff, Martin Czerny, Matthias Thielmann, Nikos Werner, Giuseppe Tarantini","doi":"10.4244/EIJ-D-23-01100","DOIUrl":null,"url":null,"abstract":"<p><p>This clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions was developed in association with the European Society of Cardiology Working Group on Cardiovascular Surgery. It aims to define procedural and contemporary technical requirements that may improve the efficacy and safety of percutaneous coronary intervention (PCI), both in the acute phase and at long-term follow-up, in a high-risk cohort of patients on optimal medical therapy when clinical and anatomical high-risk criteria are present that entail unacceptable surgical risks, precluding the feasibility of coronary artery bypass grafting (CABG). This document pertains to patients with surgical contraindication according to the Heart Team, in whom medical therapy has failed (e.g., residual symptoms), and for whom the Heart Team estimates that revascularisation may have a prognostic benefit (e.g., left main, last remaining vessel, multivessel disease with large areas of ischaemia); however, there is a lack of data regarding the size of this patient population. This document aims to guide interventional cardiologists on how to proceed with PCI in such high-risk patients with reduced left ventricular ejection fraction after the decision of the Heart Team is made that CABG - which overall is the guideline-recommended option for revascularisation in these patients - is not an option and that PCI may be beneficial for the patient. Importantly, when a high-risk PCI is planned, a multidisciplinary decision by interventional cardiologists, cardiac surgeons, anaesthetists and non-invasive physicians with expertise in heart failure management and intensive care should be agreed upon after careful consideration of the possible undesirable consequences of PCI, including futility, similar to the approach for structural interventions.</p>","PeriodicalId":54378,"journal":{"name":"Eurointervention","volume":"21 1","pages":"22-34"},"PeriodicalIF":7.6000,"publicationDate":"2025-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11687390/pdf/","citationCount":"0","resultStr":"{\"title\":\"High-risk percutaneous coronary intervention in patients with reduced left ventricular ejection fraction deemed not suitable for surgical revascularisation. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) in collaboration with the ESC Working Group on Cardiovascular Surgery.\",\"authors\":\"Andreas Schäfer, Mirvat Alasnag, Daniele Giacoppo, Carlos Collet, Tanja K Rudolph, Ariel Roguin, Piotr P Buszman, Roisin Colleran, Giulio Stefanini, Thierry Lefevre, Nicolas Van Mieghem, Guillaume Cayla, Christoph Naber, Andreas Baumbach, Adam Witkowski, Francesco Burzotta, Davide Capodanno, Dariusz Dudek, Rasha Al-Lamee, Adrian Banning, Philip MacCarthy, Roman Gottardi, Florian S Schoenhoff, Martin Czerny, Matthias Thielmann, Nikos Werner, Giuseppe Tarantini\",\"doi\":\"10.4244/EIJ-D-23-01100\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>This clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions was developed in association with the European Society of Cardiology Working Group on Cardiovascular Surgery. It aims to define procedural and contemporary technical requirements that may improve the efficacy and safety of percutaneous coronary intervention (PCI), both in the acute phase and at long-term follow-up, in a high-risk cohort of patients on optimal medical therapy when clinical and anatomical high-risk criteria are present that entail unacceptable surgical risks, precluding the feasibility of coronary artery bypass grafting (CABG). This document pertains to patients with surgical contraindication according to the Heart Team, in whom medical therapy has failed (e.g., residual symptoms), and for whom the Heart Team estimates that revascularisation may have a prognostic benefit (e.g., left main, last remaining vessel, multivessel disease with large areas of ischaemia); however, there is a lack of data regarding the size of this patient population. This document aims to guide interventional cardiologists on how to proceed with PCI in such high-risk patients with reduced left ventricular ejection fraction after the decision of the Heart Team is made that CABG - which overall is the guideline-recommended option for revascularisation in these patients - is not an option and that PCI may be beneficial for the patient. Importantly, when a high-risk PCI is planned, a multidisciplinary decision by interventional cardiologists, cardiac surgeons, anaesthetists and non-invasive physicians with expertise in heart failure management and intensive care should be agreed upon after careful consideration of the possible undesirable consequences of PCI, including futility, similar to the approach for structural interventions.</p>\",\"PeriodicalId\":54378,\"journal\":{\"name\":\"Eurointervention\",\"volume\":\"21 1\",\"pages\":\"22-34\"},\"PeriodicalIF\":7.6000,\"publicationDate\":\"2025-01-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11687390/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Eurointervention\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.4244/EIJ-D-23-01100\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Eurointervention","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4244/EIJ-D-23-01100","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

摘要

欧洲经皮心血管介入治疗协会的这一临床共识声明是与欧洲心脏病学会心血管外科工作组联合制定的。本研究的目的是确定程序和当代技术要求,以提高经皮冠状动脉介入治疗(PCI)的疗效和安全性,无论是在急性期还是在长期随访中,在一组接受最佳药物治疗的高危患者中,当临床和解剖学上的高危标准存在不可接受的手术风险,排除了冠状动脉旁路移植术(CABG)的可行性。本文件适用于心脏小组认为有手术禁忌症的患者,其中药物治疗失败(例如,残留症状),并且心脏小组估计对其进行血运重建可能有预后益处(例如,左主干,最后剩余血管,多血管疾病伴大面积缺血);然而,缺乏关于这一患者群体规模的数据。本文档旨在指导介入心脏病专家在心脏小组决定CABG(总体上是这些患者血运重建的指南推荐选择)不是一种选择,并且PCI可能对患者有益后,如何对左室射血分数降低的高危患者进行PCI。重要的是,当计划进行高风险PCI时,介入心脏病专家、心脏外科医生、麻醉师和具有心力衰竭管理和重症监护专业知识的非侵入性医生应在仔细考虑PCI可能的不良后果(包括无效)后达成多学科决策,类似于结构干预的方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
High-risk percutaneous coronary intervention in patients with reduced left ventricular ejection fraction deemed not suitable for surgical revascularisation. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) in collaboration with the ESC Working Group on Cardiovascular Surgery.

This clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions was developed in association with the European Society of Cardiology Working Group on Cardiovascular Surgery. It aims to define procedural and contemporary technical requirements that may improve the efficacy and safety of percutaneous coronary intervention (PCI), both in the acute phase and at long-term follow-up, in a high-risk cohort of patients on optimal medical therapy when clinical and anatomical high-risk criteria are present that entail unacceptable surgical risks, precluding the feasibility of coronary artery bypass grafting (CABG). This document pertains to patients with surgical contraindication according to the Heart Team, in whom medical therapy has failed (e.g., residual symptoms), and for whom the Heart Team estimates that revascularisation may have a prognostic benefit (e.g., left main, last remaining vessel, multivessel disease with large areas of ischaemia); however, there is a lack of data regarding the size of this patient population. This document aims to guide interventional cardiologists on how to proceed with PCI in such high-risk patients with reduced left ventricular ejection fraction after the decision of the Heart Team is made that CABG - which overall is the guideline-recommended option for revascularisation in these patients - is not an option and that PCI may be beneficial for the patient. Importantly, when a high-risk PCI is planned, a multidisciplinary decision by interventional cardiologists, cardiac surgeons, anaesthetists and non-invasive physicians with expertise in heart failure management and intensive care should be agreed upon after careful consideration of the possible undesirable consequences of PCI, including futility, similar to the approach for structural interventions.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Eurointervention
Eurointervention CARDIAC & CARDIOVASCULAR SYSTEMS-
CiteScore
10.30
自引率
4.80%
发文量
380
审稿时长
3-8 weeks
期刊介绍: EuroIntervention Journal is an international, English language, peer-reviewed journal whose aim is to create a community of high quality research and education in the field of percutaneous and surgical cardiovascular interventions.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信